全球醫生調劑藥用化妝品市場：按產品類型、應用和地區的規模和預測

醫生調劑藥用化妝品的市場規模與預測

2024年醫生調劑藥用化妝品市場規模達到 95.9億美元，預計到2032年將達到 190.8億美元，2026年至2032年的年複合成長率為 8.98%。

人們對美的本質和前景以及抗衰老的認知不斷提高，預計將推動醫生調劑藥用化妝品市場的成長。預計在預測期內，人們對醫生藥用化妝品的安全性和有效性的認知不斷提高，以及消費者對各種皮膚問題的具體解決方案（如減少老齡化斑和痤瘡疤痕）的需求不斷成長等因素將進一步推動醫生藥用化妝品市場的成長。

定義醫生調劑藥用化妝品的全球市場

藥用化妝品是含有藥用成分的化妝品。這些產品不需要法律檢驗醫生調劑藥用化妝品是僅透過醫學指示的企業提供的化妝品，目的是對角質層以下的皮膚產生實際的生物學作用。許多選擇配製這些藥用化妝品的醫生都有包括皮膚健康的實踐或專長醫生調劑藥用化妝品產品包括護膚、眼部護理產品和頭髮護理產品。

這些產品專門針對老化徵兆、感染疾病和其他個人外觀問題而設計醫生調劑藥用化妝品是指僅透過醫學指示的企業提供的產品，目的是對角質層下的皮膚產生實際的生物學作用。醫生調劑藥用化妝品包括由皮膚科醫師、毛髮學家、整形外科醫師和其他醫療相關人員配製的藥用化妝品。

全球醫生藥用化妝品市場概覽

人們越來越重視美麗和外表，以及抗衰老意識的不斷增強，是預計推動全球醫生藥用化妝品市場成長的關鍵因素。此外，人們對醫生藥用化妝品的安全性和有效性的認知不斷提高以及新產品的推出也是推動全球市場成長的其他因素。

此外，醫生藥用化妝品是訂製產品，比普通的非處方產品更能滲透到皮膚深處。

這些產品具有更深的滲透力，因此可以提供更好的早期效果，這是推動該市場成長的主要因素。大多數醫美產品都是由醫生、皮膚專家和科學家設計和配製的，他們花費數年時間研究成分，並在自己的診所中實施，以治療預期目標。此外，美麗和外表的日益重要、抗衰老意識的不斷增強以及對醫生藥用化妝品的安全性和有效性的認知不斷增強也是推動市場成長的因素。

目錄

第1章 全球醫生調劑藥用化妝品市場簡介

• 市場概覽
• 研究範圍
• 先決條件

第2章 執行摘要

第3章 已驗證的市場研究調查方法

• 資料探勘
• 驗證
• 第一手資料
• 資料來源列表

第4章 全球醫生調劑藥用化妝品市場展望

• 概述
• 市場動態
  • 促進因素
  • 限制因素
  • 機會
• 波特五力模型
• 價值鏈分析

第5章 全球醫師配製的藥用化妝品市場（依產品類型）

• 概述
• 護膚產品
• 護髮產品
• 眼部護理產品

第6章 全球醫生調劑藥用化妝品市場（依應用）

• 概述
• 醫院藥房
• 零售藥局
• 網路銷售

第7章 全球醫生藥用化妝品市場（依地區）

• 概述
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 其他
  • 拉丁美洲
  • 中東和非洲

第8章 全球醫生調劑藥用化妝品市場的競爭格局

• 概述
• 各公司市場排名
• 重點發展策略

第9章 公司簡介

• Johnson & Johnson
• Allergan plc
• Procter & Gamble Co.
• Jan Marini Skin Research, Inc.
• L'Oreal SA
• Bausch Health Companies Inc.
• Unilever plc
• ZO Skin Health Inc.
• Obagi Cosmeceuticals LLC
• Merz Pharma

第10章 重大進展

• 產品發布/開發
• 合併與收購
• 業務擴展
• 夥伴關係與合作

第11章 附錄

• 相關調查

Physician Dispensed Cosmeceuticals Market Size And Forecast

Physician Dispensed Cosmeceuticals Market size was valued at USD 9.59 Billion in 2024 and is projected to reach USD 19.08 Billion by 2032, growing at a CAGR of 8.98% from 2026 to 2032.

The growing of essence of beauty and outlook, and the increasing consciousness about anti-aging, will encourage the growth of the Physician Dispensed Cosmeceuticals Market. Factors such as the growing knowledge about the security and effectiveness of Physician Dispensed Cosmeceuticals and escalating disposition of users towards a certain solution to diverse skin problems about age spot or acne spot reduction are anticipated to further propel the growth of the Physician Dispensed Cosmeceuticals Market during the forecast period.

Global Physician Dispensed Cosmeceuticals Market Definition

Cosmeceuticals are cosmetics that consist of medicinal properties. These products do not require any legal verification. Physician Dispensed Cosmeceuticals are cosmetic products that are only available through a medically directed business and are geared towards creating actual biological actions on the skin below the stratum corneum. There are many physicians who choose to dispense these cosmeceuticals whose practices or specialties involve skin health. Physician Dispensed Cosmeceuticals involve the products such as skin care, eye care, hair care products, and others.

These products are specially designed to target the signs of aging, infections, and other personal appearances. Physician Dispensed Cosmeceuticals refer to products that are only available through a medically directed business and are geared towards creating actual biological actions on the skin below the stratum corneum. Physician Dispensed Cosmeceuticals include medicated aesthetic products referred by dermatologists, trichologists, cosmetic surgeons, and allied medical professionals.

Global Physician Dispensed Cosmeceuticals Market Overview

Rising importance regarding beauty and appearance and increasing awareness about anti-aging are the primary factors expected to fuel the growth of the Global Physician Dispensed Cosmeceuticals Market. Furthermore, increasing awareness regarding the safety and efficacy of physician-dispensed cosmeceuticals and new product launches are other factors contributing to the growth of the global market.

Moreover, Physician Dispensed Cosmeceuticals are custom-made products that penetrate deeper into the skin than normal OTC products.

As these products are deeply penetrated, it provides early and better results which is the prime factor responsible for the growth of this market. Most Physician lines are designed and formulated by physicians, skin professionals, and scientists who have researched ingredients for many years and put them into action in their own practices to treat intended targets. Additionally, the increasing importance of beauty and appearance, growing awareness about anti-aging, and increasing awareness about the safety and efficacy of physician-dispensed cosmeceuticals are the other factors that are contributing to the growth of the market.

Global Physician Dispensed Cosmeceuticals Market: Segmentation Analysis

The Global Physician Dispensed Cosmeceuticals Market is segmented on the basis of Product Type, Application, and Geography.

Physician Dispensed Cosmeceuticals Market, By Product Type

• Skin care products
• Hair care products
• Eye care products

Based on Product Type, the market is bifurcated into Skin care products, Hair care products, and Eye care products. The skincare products segment accounted for a prominent share of the Global Physician Dispensed Cosmeceuticals Market in 2022, as the nature of cosmeceuticals demanded by consumers is largely to treat dermatological conditions. Increasing awareness about personal maintenance among the geriatric population and changing attitudes of middle-aged and geriatric populations in developing countries have fuelled the demand for cosmeceuticals in order to eliminate the outward signs of aging.

Physician Dispensed Cosmeceuticals Market, By Application

• Hospital Pharmacy
• Retail Pharmacy
• Online Sales

Based on the Application, the market is bifurcated into Hospital Pharmacy, Retail Pharmacy, and Online Sales.

Physician Dispensed Cosmeceuticals Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
• On the basis of Regional Analysis, The Global Physician Dispensed Cosmeceuticals Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Asia Pacific region is expected to grow significantly over the forecast period. A growing preference to behold long-lasting youthful appearance and beauty is driving the demand for effective physician-dispensed cosmeceuticals in the region. Furthermore, the growing focus of key market players on expansion in Asia Pacific countries, the huge customer base in the region, and rising awareness about physician-dispensed cosmeceuticals will also drive the market in the Asia Pacific.

Key Players

The "Global Physician Dispensed Cosmeceuticals Market" study report will provide valuable insight emphasizing the global market. The major players in the market are Johnson & Johnson, Allergan plc, Procter & Gamble Co., Jan Marini Skin Research, Inc., L'Oreal S.A., Bausch Health Companies Inc., Unilever plc, ZO Skin Health Inc., Merz Pharma, and Obagi Cosmeceuticals LLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In 2019, Galderma, a leading player in the physician-dispensed cosmeceuticals market, announced a partnership with Colorescience, a cosmetics company that specializes in mineral-based sunscreens and other skincare products. The partnership aimed to offer a wider range of skincare options to patients and consumers.
• In October 2021, Huons Biopharma signed a contract worth 97.2 billion won with German-based pharmaceutical company Haemato Pharm to distribute its botulinum toxin product exclusively to the European market. Thus, such instances show an increase in demand for physician-dispensed cosmeceuticals, which is ultimately driving market growth.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into Active, Cutting Edge, Emerging, and Innovators categories.
• Market Attractiveness
• The image of market attractiveness provided further helps to get information about the region leading in the Global Physician Dispensed Cosmeceuticals Market. We cover the major impacting factors driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Physician Dispensed Cosmeceuticals Market, gauge the attractiveness of a particular sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Skin care products
• 5.3 Hair care products
• 5.4 Eye care products

6 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Hospital Pharmacy
• 6.3 Retail Pharmacy
• 6.4 Online Sales

7 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Johnson & Johnson
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Allergan plc
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Procter & Gamble Co.
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Jan Marini Skin Research, Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 L'Oreal S.A.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Bausch Health Companies Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Unilever plc
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 ZO Skin Health Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Obagi Cosmeceuticals LLC
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Merz Pharma
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research